Mechanisms of immune evasion and current status of checkpoint inhibitors in non-small cell lung cancer. [electronic resource]
Producer: 20171116Description: 2567-78 p. digitalISSN:- 2045-7634
- Animals
- Antibodies, Monoclonal -- pharmacology
- Antineoplastic Agents -- pharmacology
- B7-H1 Antigen -- antagonists & inhibitors
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Humans
- Immune System -- cytology
- Immune Tolerance -- drug effects
- Immunologic Factors -- pharmacology
- Immunotherapy
- Lung Neoplasms -- drug therapy
- Molecular Targeted Therapy
- Programmed Cell Death 1 Receptor -- antagonists & inhibitors
- T-Lymphocyte Subsets -- drug effects
- Tumor Escape -- drug effects
- Tumor Microenvironment -- immunology
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.